JP Stock MarketDetailed Quotes

268A Rigaku Holdings

Watchlist

926
-4-0.43%

20min DelayTrading Dec 16 13:38 JST

208.60BMarket Cap19.13P/E (Static)

Rigaku Holdings Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(FY)Dec 31, 2022

Operating cash flow (Indirect Method)

Cash from operating activities

30.61%16.33B

12.51B

Net profit before non-cash adjustment

380.12%14.83B

--3.09B

Total adjustment of non-cash items

-60.05%4.93B

--12.33B

-Depreciation and amortization

13.67%4.41B

--3.88B

-Reversal of impairment losses recognized in profit and loss

--0

--5.42B

-Disposal profit

1,462.50%125M

--8M

-Net exchange gains and losses

83.64%-35M

---214M

-Other non-cash items

-86.77%429M

--3.24B

Changes in working capital

-17.23%-3.42B

---2.92B

-Change in receivables

-133.89%-3.2B

---1.37B

-Change in inventory

31.93%-3.24B

---4.76B

-Change in payables

-169.41%-1.05B

--1.51B

-Provision for loans, leases and other losses

--445M

--0

-Changes in other current assets

112.52%3.62B

--1.7B

Dividends paid (cash flow from operating activities)

Dividends received (cash flow from operating activities)

Interest paid (cash flow from operating activities)

61.51%-642M

-1.67B

Interest received (cash flow from operating activities)

266.04%194M

53M

Tax refund paid

-142.06%-4.16B

-1.72B

Other operating cash inflow (outflow)

99.94%-1M

-1.81B

Operating cash flow

59.21%11.72B

--7.36B

Investing cash flow

Net PPE purchase and sale

2.53%-2.58B

---2.64B

Net intangibles purchase and sale

-91.67%-46M

---24M

Net investment product transactions

-128.81%-17M

--59M

Net changes in other investments

5,540.00%282M

--5M

Investing cash flow

9.45%-2.36B

---2.6B

Financing cash flow

Net issuance payments of debt

-17.40%-3.33B

---2.84B

Net common stock issuance

-36.91%147M

--233M

Increase or decrease of lease financing

-34.46%-839M

---624M

Net other fund-raising expenses

100.50%2M

---401M

Financing cash flow

-10.80%-4.02B

---3.63B

Net cash flow

Beginning cash position

14.76%14.43B

--12.58B

Current changes in cash

373.58%5.34B

--1.13B

Effect of exchange rate changes

2.33%747M

--730M

Cash adjustments other than cash changes

150.00%1M

---2M

End cash Position

42.20%20.52B

--14.43B

Free cash flow

91.58%8.9B

--4.64B

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Dec 31, 2023	(FY)Dec 31, 2022
Operating cash flow (Indirect Method)
Cash from operating activities	30.61%16.33B	12.51B
Net profit before non-cash adjustment	380.12%14.83B	--3.09B
Total adjustment of non-cash items	-60.05%4.93B	--12.33B
-Depreciation and amortization	13.67%4.41B	--3.88B
-Reversal of impairment losses recognized in profit and loss	--0	--5.42B
-Disposal profit	1,462.50%125M	--8M
-Net exchange gains and losses	83.64%-35M	---214M
-Other non-cash items	-86.77%429M	--3.24B
Changes in working capital	-17.23%-3.42B	---2.92B
-Change in receivables	-133.89%-3.2B	---1.37B
-Change in inventory	31.93%-3.24B	---4.76B
-Change in payables	-169.41%-1.05B	--1.51B
-Provision for loans, leases and other losses	--445M	--0
-Changes in other current assets	112.52%3.62B	--1.7B
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)	0	0
Interest paid (cash flow from operating activities)	61.51%-642M	-1.67B
Interest received (cash flow from operating activities)	266.04%194M	53M
Tax refund paid	-142.06%-4.16B	-1.72B
Other operating cash inflow (outflow)	99.94%-1M	-1.81B
Operating cash flow	59.21%11.72B	--7.36B
Investing cash flow
Net PPE purchase and sale	2.53%-2.58B	---2.64B
Net intangibles purchase and sale	-91.67%-46M	---24M
Net investment product transactions	-128.81%-17M	--59M
Net changes in other investments	5,540.00%282M	--5M
Investing cash flow	9.45%-2.36B	---2.6B
Financing cash flow
Net issuance payments of debt	-17.40%-3.33B	---2.84B
Net common stock issuance	-36.91%147M	--233M
Increase or decrease of lease financing	-34.46%-839M	---624M
Net other fund-raising expenses	100.50%2M	---401M
Financing cash flow	-10.80%-4.02B	---3.63B
Net cash flow
Beginning cash position	14.76%14.43B	--12.58B
Current changes in cash	373.58%5.34B	--1.13B
Effect of exchange rate changes	2.33%747M	--730M
Cash adjustments other than cash changes	150.00%1M	---2M
End cash Position	42.20%20.52B	--14.43B
Free cash flow	91.58%8.9B	--4.64B
Currency Unit	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP

Symbol Price % Chg

D. Western Therapeutics Institute

See the daily top gainer.